Elanco Animal Health reported a 3% increase in revenue to $1,257 million for Q1 2023, driven by customer purchases shifting from Q2 due to ERP integration. The company raised the bottom end of its full-year guidance, reflecting confidence in U.S. Pet Health and international poultry businesses.
Revenue increased by 3% on a reported basis, or 6% excluding the unfavorable impact from foreign exchange rates.
Pet Health revenue increased by 5%, driven by price, but impacted by supply constraints and competition.
Farm Animal revenue increased by 1%, driven by strength in Europe and Asia, offset by poultry rotations and supply constraints.
The company estimates adjusted EPS in the first quarter includes a $0.11 to $0.14 benefit from the ERP Blackout.
Elanco is updating financial guidance for the full year 2023, driven by the successful completion of the ERP system integration, innovation progress, and increased confidence in the company’s U.S. Pet Health and international poultry businesses.
Visualization of income flow from segment revenue to net income